KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Insufficient enrolments. This was mentioned at one stage for the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. spyglass
    1,345 Posts.
    lightbulb Created with Sketch. 141
    clock Created with Sketch.
    27/06/22
    15:23
    Post #: 62229580
    Insufficient enrolments. This was mentioned at one stage for the P2 BCBM trial run by Jose Pablo Leone. Also I don't think that interim readout of the Pax single treatment DIPG trial was showing any overall survival extension so I'm not confident on that (which is why mobbing it to combo trials will hopefully be better).
    But I am expecting positive results from the Alliance trial that has recently progressed the Pax arm
    Last edited by spyglass: 27/06/22
    KZA Price at posting: 63.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.